Familial Aggregation of Irritable Bowel Syndrome: a Prospective Study

Overview

Journal Gut

Specialty Gastroenterology

Date 2003 Nov 25

PMID 14633946

Citations 56

Authors

J S Kalantar

G R Locke 3rd

A R Zinsmeister

C M Beighley

N J Talley

Affiliations

Soon will be listed here.

Abstract

Background: Patients with irritable bowel syndrome (IBS) often report family members with similar symptoms, but family studies are lacking. We hypothesised that if there is familial aggregation, there would be an increased frequency of IBS in first degree relatives of IBS patients compared with relatives of controls (the patient's spouse).

Methods: A valid self report bowel disease questionnaire (BDQ) that recorded symptoms, the somatic symptom checklist (a measure of somatisation), and a family information form (FIF) to collect the names and addresses of all first degree relatives were mailed to two groups of patients and their spouses (patients attending an IBS educational programme and residents of Olmsted County, Minnesota, who had been coded as IBS on a database). A BDQ was then mailed to all first degree relatives of subjects identified from the FIF. IBS diagnosis in the relatives was based on the Manning criteria.

Results: The BDQ was sent to a total of 355 eligible relatives; 71% responded (73% relatives of patients, 67% relatives of spouses). Relatives were comparable in mean age, sex distribution, and somatisation score. IBS prevalence was 17% in patients' relatives versus 7% in spouses' relatives (odds ratio adjusted for age and sex 2.7 (95% confidence interval (CI) 1.2, 6.3)). When also adjusted for somatisation score, the odds ratio was reduced to 2.5 (95% CI 0.9, 6.7).

Conclusions: Familial aggregation of IBS occurs, supporting a genetic or intrafamilial environment component, but this may be explained in part by familial aggregation of somatisation.

Citing Articles

Pharmacogenetics in IBS: update and impact of GWAS studies in drug targets and metabolism.

Camilleri M, Jencks K Expert Opin Drug Metab Toxicol. 2024; 20(5):319-332.

PMID: 38785066 PMC: 11139426. DOI: 10.1080/17425255.2024.2349716.

Assessment of Sleep Quality Among Adolescents and Adults With Self-Diagnosed Irritable Bowel Syndrome, in Jeddah, Saudi Arabia.

Alghamdi A, Alghamdi A, Alshareef M, Alghamdi A, Alghamdi R, AlAmri A Cureus. 2023; 15(7):e42778.

PMID: 37663979 PMC: 10469519. DOI: 10.7759/cureus.42778.

Irritable Bowel Syndrome: Prevalence and Determinants Among Adults in the Makkah Region, Saudi Arabia.

Hafiz T, Alhemayed T, Mandorah R, Alshanqiti A, Almohaimeed R, Noor O Cureus. 2023; 15(5):e39568.

PMID: 37378098 PMC: 10292633. DOI: 10.7759/cureus.39568.

Effects of irritable bowel syndrome on the health-related quality of life among the Saudi population.

Aljahdli E, Badroun F, Mushaeb H, Aljohani R, Albisher S, Basalaim L Saudi J Gastroenterol. 2023; 30(1):37-44.

PMID: 37357494 PMC: 10852141. DOI: 10.4103/sjg.sjg_107_23.

Clinical efficacy of one-finger meditation massage on IBS-C based on the "gut-brain axis" theory: study protocol for a randomized controlled trial.

Zeng X, He J, Li X, Chen P, Zuo J, Cai X BMC Complement Med Ther. 2023; 23(1):185.

PMID: 37280574 PMC: 10245512. DOI: 10.1186/s12906-023-04019-3.

References

Kendler K, Walters E, Truett K, Heath A, Neale M, Martin N . A twin-family study of self-report symptoms of panic-phobia and somatization. Behav Genet. 1995; 25(6):499-515. DOI: 10.1007/BF02327574. View

Barbezat G, Poulton R, Milne B, Howell S, Fawcett J, Talley N . Prevalence and correlates of irritable bowel symptoms in a New Zealand birth cohort. N Z Med J. 2003; 115(1164):U220. View

Talley N, Zinsmeister A, Van Dyke C, Melton 3rd L . Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology. 1991; 101(4):927-34. DOI: 10.1016/0016-5085(91)90717-y. View

Melton 3rd L . History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996; 71(3):266-74. DOI: 10.4065/71.3.266. View

Saito Y, Schoenfeld P, Richard Locke 3rd G . The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol. 2002; 97(8):1910-5. DOI: 10.1111/j.1572-0241.2002.05913.x. View

Drossman D, MCKEE D, Sandler R, Mitchell C, Cramer E, Lowman B . Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology. 1988; 95(3):701-8. DOI: 10.1016/s0016-5085(88)80017-9. View

Whitehead W, Palsson O, Jones K . Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?. Gastroenterology. 2002; 122(4):1140-56. DOI: 10.1053/gast.2002.32392. View

Locke 3rd G, Zinsmeister A, Talley N, Fett S, Melton 3rd L . Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc. 2000; 75(9):907-12. DOI: 10.4065/75.9.907. View

Talley N, Spiller R . Irritable bowel syndrome: a little understood organic bowel disease?. Lancet. 2002; 360(9332):555-64. DOI: 10.1016/S0140-6736(02)09712-X. View

10.

Camilleri M, Atanasova E, Carlson P, Ahmad U, Jae Kim H, Viramontes B . Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology. 2002; 123(2):425-32. DOI: 10.1053/gast.2002.34780. View

11.

Boyce P, Koloski N, Talley N . Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?. Am J Gastroenterol. 2000; 95(11):3176-83. DOI: 10.1111/j.1572-0241.2000.03197.x. View

12.

Whitehead W, Palsson O . Is rectal pain sensitivity a biological marker for irritable bowel syndrome: psychological influences on pain perception. Gastroenterology. 1998; 115(5):1263-71. DOI: 10.1016/s0016-5085(98)70099-x. View

13.

Talley N, Gabriel S, Harmsen W, Zinsmeister A, Evans R . Medical costs in community subjects with irritable bowel syndrome. Gastroenterology. 1995; 109(6):1736-41. DOI: 10.1016/0016-5085(95)90738-6. View

14.

Drossman D, Talley N, Leserman J, Olden K, Barreiro M . Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med. 1995; 123(10):782-94. DOI: 10.7326/0003-4819-123-10-199511150-00007. View

15.

Talley N, Fett S, Zinsmeister A, Melton 3rd L . Gastrointestinal tract symptoms and self-reported abuse: a population-based study. Gastroenterology. 1994; 107(4):1040-9. DOI: 10.1016/0016-5085(94)90228-3. View

16.

Colwell L, Prather C, Phillips S, Zinsmeister A . Effects of an irritable bowel syndrome educational class on health-promoting behaviors and symptoms. Am J Gastroenterol. 1998; 93(6):901-5. DOI: 10.1111/j.1572-0241.1998.00273.x. View

17.

Berman S, Chang L, Suyenobu B, Derbyshire S, Stains J, Fitzgerald L . Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron. Gastroenterology. 2002; 123(4):969-77. DOI: 10.1053/gast.2002.35990. View

18.

Bonaz B, Baciu M, Papillon E, Bost R, Gueddah N, Le Bas J . Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study. Am J Gastroenterol. 2002; 97(3):654-61. DOI: 10.1111/j.1572-0241.2002.05545.x. View

19.

Mohammed I, Cherkas L, Riley S, Spector T, Trudgill N . Genetic influences in irritable bowel syndrome: a twin study. Am J Gastroenterol. 2005; 100(6):1340-4. DOI: 10.1111/j.1572-0241.2005.41700.x. View

20.

Sandler R, Everhart J, Donowitz M, Adams E, Cronin K, Goodman C . The burden of selected digestive diseases in the United States. Gastroenterology. 2002; 122(5):1500-11. DOI: 10.1053/gast.2002.32978. View